Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays updated Study Record Dates, including Results First Posted and last update timestamps. This indicates that trial results have been posted and the record was refreshed in 2025.
    Difference
    0.4%
    Check dated 2025-11-03T21:08:19.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    2%
    Check dated 2025-10-06T05:30:45.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.0%
    Check dated 2025-09-29T03:04:08.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:14:14.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T15:39:40.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and location, along with a comprehensive list of new chemical compounds and proteins. Notably, previous entries related to antineoplastic agents and immune checkpoint inhibitors have been removed.
    Difference
    2%
    Check dated 2025-08-31T11:58:14.000Z thumbnail image

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.